Pharma.Aero welcomes 4Viso as a new member of the global cross-industry collaboration platform, further strengthening the community’s expertise in digital compliance and audit management across pharmaceutical supply chains.
4Viso provides a digital platform designed to manage partner standards, capability data, and audit programmes across complex logistics networks. By integrating compliance intelligence with operational and audit data, the platform supports a shift from reactive quality management towards a more proactive and structured approach to supply chain risk management.
As pharmaceutical supply chains continue to evolve – becoming more interconnected, data-driven, and risk-sensitive -, the need for greater transparency, standardisation, and real-time oversight is increasingly evident. Digital solutions that enable consistent visibility across partners and processes play a key role in addressing these challenges.
Joining Pharma.Aero is a natural step for us. As pharmaceutical supply chains grow more complex, trusted data and collaboration across partners become increasingly important. We look forward to contributing our expertise in digital compliance, risk intelligence, and predictive analytics while working with the Pharma.Aero community to strengthen resilient and transparent pharma logistics.
Stefan Hollands, CEO & Founder, 4Viso
By joining Pharma.Aero, 4Viso becomes part of a global network of stakeholders across the life sciences supply chain, working collaboratively to advance best practices, share operational insights, and support the development of more resilient and efficient end-to-end logistics. This collaboration reinforces the importance of integrating digital capabilities into quality and risk management frameworks, ensuring that pharmaceutical supply chains remain robust, compliant, and responsive to an increasingly dynamic global environment.